Morphogen-induced decline in Gialpha2 triggers F9 teratocarcinoma stem cell progression via phospholipase C and
1Department of Molecular Pharmacology, Diabetes and Metabolic Diseases Research Program, University Medical Center-HSC, State University of New York, Stony Brook, New York 11794-8651, USA.
Abstract:
The linkage between Gialpha2 and morphogen-induced promotion of F9 embryonic teratocarcinoma stem (F9 stem) cells to primitive endoderm was explored using probes of the mitogen-activated protein (MAP) kinase network. The morphogen-induced decline in Gialpha2 is shown to trigger activation of phospholipase C, thereby activating protein kinase C, MAP kinase, and cell progression to primitive endoderm. In the absence of retinoic acid, reduction-of-function mutants (Gialpha2-deficient) display the effects of morphogen, i.e. activation of phospholipase C, protein kinase C, MAP kinase, and progression to primitive endoderm. Gain-of-function mutants (expressing the Q205L activating-mutation of Gialpha2) displayed no activation of phospholipase C, protein kinase C, MAP kinase and no progression to primitive endoderm, even in the presence of retinoic acid. Selective inhibitors of protein kinase C, like the gain-of-function mutations, effectively block morphogen-induced progression to primitive endoderm. Morphogen triggers F9 stem cell progression by triggering Gialpha2 loss and thereby activation of downstream elements, including protein kinase C and MAP kinase.
Insights
G-protein alpha subunit Gialpha2 loss triggers stem cell differentiation. This activates key signaling pathways like protein kinase C and MAP kinase, promoting primitive endoderm formation in F9 stem cells.
Area of Science:
- Cell Biology
- Developmental Biology
- Signal Transduction
Background:
- F9 embryonic stem cells differentiate into primitive endoderm in response to morphogens.
- The role of G-protein alpha subunits, specifically Gialpha2, in this differentiation process is not fully understood.
- Mitogen-activated protein (MAP) kinase pathways are implicated in cellular differentiation.
Purpose of the Study:
- To investigate the role of Gialpha2 in morphogen-induced differentiation of F9 stem cells.
- To elucidate the signaling network connecting Gialpha2 to the MAP kinase pathway during primitive endoderm formation.
Main Methods:
- Utilized reduction-of-function (Gialpha2-deficient) and gain-of-function (Gialpha2 Q205L mutant) F9 stem cell lines.
- Employed selective inhibitors of protein kinase C.
- Analyzed the activation of phospholipase C, protein kinase C, and MAP kinase.
Main Results:
- Morphogen-induced differentiation involves a decline in Gialpha2, activating phospholipase C, protein kinase C, and MAP kinase.
- Gialpha2-deficient cells mimicked morphogen effects, showing pathway activation and differentiation.
- Gain-of-function mutants and protein kinase C inhibitors blocked differentiation, confirming Gialpha2's inhibitory role on the pathway.
Conclusions:
- Gialpha2 acts as a negative regulator in the morphogen-induced differentiation pathway of F9 stem cells.
- Loss of Gialpha2 is essential for activating downstream signaling, including protein kinase C and MAP kinase, leading to primitive endoderm formation.
More Related Videos
07:43An Enzyme- and Serum-free Neural Stem Cell Culture Model for EMT Investigation Suited for Drug Discovery
Published on: August 23, 2016
10:28Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
Published on: January 10, 2018
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
